A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/260
A61K 31/19 (2006.01)
Patent
CA 1323575
ABSTRACT Bezafibrate, also known as 2-[4-[2-(4-chloro- benzamido)-ethyl]-phenoxy]-2-methylpropionic acid, is found to be useful for the treatment of normolipidaemic diabetes mellitus type II; medicaments are provided for combating normolipidaemic diabetes mellitus type II which contain bezafibrate.
576196
Boehringer Mannheim Gmbh
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Use of bezafibrate for treating diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of bezafibrate for treating diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bezafibrate for treating diabetes will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1312490